Heat-inducible amplifier vector for high-level expression of granulocyte-macrophage colony-stimulating factor

International Journal of Hyperthermia

Volumn 22, Issue 5, 2006, Pages 407-419

  Dammeyer, Pascal ^a,b   Jaramillo, Melba C ^a   Pipes, Brian L ^a   Badowski, Michael S ^a   Tsang, Tom C ^a   Harris, David T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amplifier vector; GM CSF; Hyperthermia; Inducible; Localized expression

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEAT SHOCK PROTEIN 70; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETIC CODE; HUMAN IMMUNODEFICIENCY VIRUS 2; HYPERTHERMIC THERAPY; LONG TERMINAL REPEAT; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TEMPERATURE MEASUREMENT; TRANSCRIPTION REGULATION; TREATMENT DURATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALS; CELL LINE, TUMOR; GENE PRODUCTS, TAT; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; MELANOMA, EXPERIMENTAL;

EID: 33746941218     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.1080/02656730600765312     Document Type: Article

References (43)

1. Tagawa, M. (2000) Cytokine therapy for cancer Curr Pharm Des, 6, pp. 681-699.
2. Dranoff, G. (2002) GM-CSF-based cancer vaccines Immunol Rev, 188, pp. 147-154.
3. Ravaud, A and Delaunay, M and Chevreau, C and Coulon, V and Debled, M and Bret-Dibat, C and Courbon, F and Gualde, N and Nguyen Bui, B. (2001) Granulocyte-macrophage colony-stimulating factor alone or with dacarbazine in metastatic melanoma: A randomized phase II trial Br J Cancer, 85, pp. 1467-1471.
4. Hast, R and Hellstrom-Lindberg, E and Ohm, L and Bjorkholm, M and Celsing, F and Dahl, IM and Dybedal, I and Gahrton, G and Lindberg, G and Lerner, R and Linder, O and Lofvenberg, E and Nilsson-Ehle, H and Paul, C and Samuelsson, J and Tangen, JM and Tidefelt, U and Turesson, I and Wahlin, A and Wallvik, J and Winquist, I and Oberg, G and Bernell, P. (2003) No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: Better outcome in patients with less proliferative disease Leukemia, 17, pp. 1827-1833.
5. De Giovanni, C and Nanni, P and Forni, G. (2000) The prospects for cancer gene therapy Int J Immunopharmacol, 22, pp. 1025-1032.
6. Shi, FS and Weber, S and Gan, J and Rakhmilevich, AL and Mahvi, DM. (1999) Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF Cancer Gene Ther, 6, pp. 81-88.
7. Ju, DW and Cao, X and Acres, B. (1997) Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model Cancer Gene Ther, 4, pp. 139-144.
8. Schatzlein, AG. (2001) Non-viral vectors in cancer gene therapy: Principles and progress Anticancer Drugs, 12, pp. 275-304.
9. Buchsel, PC and Forgey, A and Grape, FB and Hamann, SS. (2002) Granulocyte macrophage colony-stimulating factor: Current practice and novel approaches Clin J Oncol Nurs, 6, pp. 198-205.
10. Armstrong, CA and Botella, R and Galloway, TH and Murray, N and Kramp, JM and Song, IS and Ansel, JC. (1996) Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells Cancer Res, 56, pp. 2191-2198.
11. Chatterjee, SK and Qin, H and Manna, S and Tripathi, PK. (1999) Recombinant vaccinia virus expressing cytokine GM-CSF as tumor vaccine Anticancer Res, 19, pp. 2869-2873.
12. Couch, M and Saunders, JK and O'Malley, BW, Jr and Pardoll, D and Jaffee, E. (2003) Genetically engineered tumor cell vaccine in a head and neck cancer model Laryngoscope, 113, pp. 552-556.
13. Salgia, R and Lynch, T and Skarin, A and Lucca, J and Lynch, C and Jung, K and Hodi, FS and Jaklitsch, M and Mentzer, S and Swanson, S and Lukanich, J and Bueno, R and Wain, J and Mathisen, D and Wright, C and Fidias, P and Donahue, D and Clift, S and Hardy, S and Neuberg, D and Mulligan, R and Webb, I and Sugarbaker, D and Mihm, M and Dranoff, G. (2003) Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma J Clin Oncol, 21, pp. 624-630.
14. Toda, M and Martuza, RL and Rabkin, SD. (2000) Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor Mol Ther, 2, pp. 324-329.
15. Marshall, E. (1995) Gene therapy's growing pains Science, 269, pp. 1050-1055.
16. Mahvi, DM and Shi, FS and Yang, NS and Weber, S and Hank, J and Albertini, M and Schiller, J and Schalch, H and Larson, M and Pharo, L and Gan, J and Heisey, D and Warner, T and Sondel, PM. (2002) Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: Report of a phase I/IB study Hum Gene Ther, 13, pp. 1711-1721.
17. Armstrong, TD and Jaffee, EM. (2002) Cytokine modified tumor vaccines Surg Oncol Clin N Am, 11, pp. 681-696.
18. Bohlius, J and Reiser, M and Schwarzer, G and Engert, A. (2003) Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma: A systematic review Br J Haematol, 122, pp. 413-423.
19. Thomas, X and Boiron, JM and Huguet, F and Reman, O and Sutton, L and Turlure, P and Garban, F and Gardin, C and Espinouse, D and Boulat, O and Lheritier, V and Fiere, D. (2004) Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: A multicenter randomized study Hematol J, 5, pp. 384-394.
20. Nelson, WG and Simons, JW and Mikhak, B and Chang, JF and DeMarzo, AM and Carducci, MA and Kim, M and Weber, CE and Baccala, AA and Goeman, MA and Clift, SM and Ando, DG and Levitsky, HI and Cohen, LK and Sanda, MG and Mulligan, RC and Partin, AW and Carter, HB and Piantadosi, S and Marshall, FF. (2000) Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies Cancer Chemother Pharmacol, 46(Suppl), pp. S67-S72.
21. Nemunaitis, J and Sterman, D and Jablons, D and Smith, JW, 2nd and Fox, B and Maples, P and Hamilton, S and Borellini, F and Lin, A and Morali, S and Hege, K. (2004) Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer J Natl Cancer Inst, 96, pp. 326-331.
22. Dillman, R and Selvan, S and Schiltz, P and Peterson, C and Allen, K and Depriest, C and McClay, E and Barth, N and Sheehy, P and de Leon, C and Beutel, L. (2004) Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: Planned interim analysis Cancer Biother Radiopharm, 19, pp. 658-665.
23. Soiffer, R and Hodi, FS and Haluska, F and Jung, K and Gillessen, S and Singer, S and Tanabe, K and Duda, R and Mentzer, S and Jaklitsch, M and Bueno, R and Clift, S and Hardy, S and Neuberg, D and Mulligan, R and Webb, I and Mihm, M and Dranoff, G. (2003) Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma J Clin Oncol, 21, pp. 3343-3350.
24. Yew, NS and Wysokenski, DM and Wang, KX and Ziegler, RJ and Marshall, J and McNeilly, D and Cherry, M and Osburn, W and Cheng, SH. (1997) Optimization of plasmid vectors for high-level expression in lung epithelial cells Hum Gene Ther, 8, pp. 575-584.
25. Boshart, M and Weber, F and Jahn, G and Dorsch-Hasler, K and Fleckenstein, B and Schaffner, W. (1985) A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus Cell, 41, pp. 521-530.
26. Hartikka, J and Sawdey, M and Cornefert-Jensen, F and Margalith, M and Barnhart, K and Nolasco, M and Vahlsing, HL and Meek, J and Marquet, M and Hobart, P and Norman, J and Manthorpe, M. (1996) An improved plasmid DNA expression vector for direct injection into skeletal muscle Hum Gene Ther, 7, pp. 1205-1217.
27. Doll, RF and Crandall, JE and Dyer, CA and Aucoin, JM and Smith, FI. (1996) Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors Gene Ther, 3, pp. 437-447.
28. Tsang, TC and Brailey, JL and Vasanwala, FH and Wu, RS and Liu, F and Clark, PR and Meade-Tollin, L and Luznick, L and Stopeck, AT and Akporiaye, ET and Harris, DT. (2000) Construction of new amplifier expression vectors for high levels of IL-2 gene expression Int J Mol Med, 5, pp. 295-300.
29. Schiller, P and Amin, J and Ananthan, J and Brown, ME and Scott, WA and Voellmy, R. (1988) Cis-acting elements involved in the regulated expression of a human HSP70 gene J Mol Biol, 203, pp. 97-105.
30. Morimoto, RI and Kline, MP and Bimston, DN and Cotto, JJ. (1997) The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones Essays Biochem, 32, pp. 17-29.
31. Edwards, MJ. (1998) Apoptosis, the heat shock response, hyperthermia, birth defects, disease and cancer Where are the common links? Cell Stress Chaperones, 3, pp. 213-220.
32. Vasanwala, F and Tsang, T and Fellah, A and Yorgin, P and Harris, D. (2000) A novel expression vector induced by heat, gamma-radiation and chemotherapy Gene Ther Mol Biol, 5, pp. 1-7.
33. Tsang, TC and Harris, DT and Akporiaye, ET and Chu, RS and Brailey, J and Liu, F and Vasanwala, FH and Schluter, SF and Hersh, EM. (1997) Mammalian expression vector with two multiple cloning sites for expression of two foreign genes Biotechniques, 22, pp. 68.
34. Arya, SK and Guo, C and Josephs, SF and Wong-Staal, F. (1985) Trans-activator gene of human T-lymphotropic virus type III (HTLV-III) Science, 229, pp. 69-73.
35. Tsang, TC and Harris, DT and Akporiaye, ET and Schluter, SF and Bowden, GT and Hersh, EM. (1996) Simple method for adapting DNA fragments and PCR products to all of the commonly used restriction sites Biotechniques, 20, pp. 51-52.
36. Xu, J and Luznik, L and Wong-Staal, F and Gill, GN. (1996) Hormone receptor regulation of the human immunodeficiency virus type 1 and type 2 long terminal repeats J Biomed Sci, 3, pp. 323-331.
37. Zhang, T and Tsang, TC and Harris, DT. (2002) Comparison of cis and trans tat gene expression in HIV LTR-based amplifier vectors Biotechniques, 33, pp. 1146-1151.
38. Gerner, EW and Hersh, EM and Pennington, M and Tsang, TC and Harris, D and Vasanwala, F and Brailey, J. (2000) Heat-inducible vectors for use in gene therapy Int J Hyperthermia, 16, pp. 171-181.
39. Borrelli, MJ and Schoenherr, DM and Wong, A and Bernock, LJ and Corry, PM. (2001) Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells Cancer Res, 61, pp. 1113-1121.
40. Andrews, JM and Newbound, GC and Lairmore, MD. (1997) Transcriptional modulation of viral reporter gene constructs following induction of the cellular stress response Nucleic Acids Res, 25, pp. 1082-1084.
41. Kaul, G and Amiji, M. (2005) Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: In vitro and in vivo studies Pharm Res, 22, pp. 951-961.
42. Wolschek, MF and Thallinger, C and Kursa, M and Rossler, V and Allen, M and Lichtenberger, C and Kircheis, R and Lucas, T and Willheim, M and Reinisch, W and Gangl, A and Wagner, E and Jansen, B. (2002) Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice Hepatology, 36, pp. 1106-1114.
43. Oshima, Y and Sakamoto, T and Yamanaka, I and Nishi, T and Ishibashi, T and Inomata, H. (1998) Targeted gene transfer to corneal endothelium in vivo by electric pulse Gene Ther, 5, pp. 1347-1354.